Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON)

CUSIP: 254604101

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
37,778,373
Total 13F shares
19,879,838
Share change
+861,706
Total reported value
$933,957,855
Put/Call ratio
114%
Price per share
$46.98
Number of holders
90
Value change
+$42,877,645
Number of buys
57
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 254604101?
CUSIP 254604101 identifies IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Braden M. Leonard
3/4/5
10%+ Owner
class O/S missing
5,247,500
$354,993,375 26 Oct 2022
Atlas Venture Life Science Advisors, LLC
13F
Company
9.2%
3,461,784
$153,703,210 30 Jun 2023
13F
ORBIMED ADVISORS LLC
13F
Company
6%
2,269,637
$100,771,883 30 Jun 2023
13F
Novo Holdings A/S
3/4/5 13F
10%+ Owner · Company
2.9%
from 13F
1,090,772
$73,790,726 28 Jun 2023
Bain Capital Life Sciences Investors, LLC
13F
Company
3.5%
1,332,548
$59,165,131 30 Jun 2023
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.1%
1,162,624
$51,620,506 30 Jun 2023
13F
PERCEPTIVE ADVISORS LLC
13F
Company
2%
742,838
$32,982,007 30 Jun 2023
13F
Frazier Life Sciences Management, L.P.
13F
Company
1.7%
655,000
$29,082,000 30 Jun 2023
13F
CITADEL ADVISORS LLC
13F
Company
1.7%
651,320
$28,918,608 30 Jun 2023
13F
James B. Tananbaum
3/4/5
Director, 10%+ Owner
mixed-class rows
428,745
mixed-class rows
$27,837,975 04 Oct 2021
VANGUARD GROUP INC
13F
Company
1.5%
559,767
$24,853,654 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.5%
558,096
$24,779,462 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
1.3%
502,549
$22,313,175 30 Jun 2023
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.3%
500,379
$22,216,828 30 Jun 2023
13F
5AM Venture Management, LLC
13F
Company
1.3%
488,442
$21,686,825 30 Jun 2023
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.1%
430,000
$19,092,000 30 Jun 2023
13F
Octagon Capital Advisors LP
13F
Company
1.1%
415,000
$18,426,000 30 Jun 2023
13F
Rock Springs Capital Management LP
13F
Company
0.96%
363,468
$16,137,979 30 Jun 2023
13F
Atlas Venture Opportunity Fund II, L.P.
3/4/5
10%+ Owner
class O/S missing
218,326
$14,769,754 29 Dec 2022
FMR LLC
13F
Company
0.86%
323,054
$14,343,598 30 Jun 2023
13F
Assenagon Asset Management S.A.
13F
Company
0.65%
247,400
$10,984,560 30 Jun 2023
13F
Foresite Capital Management V, LLC
13F
Company
0.64%
243,513
$10,811,977 30 Jun 2023
13F
Ikarian Capital, LLC
13F
Company
0.64%
240,031
$10,657,376 30 Jun 2023
13F
Cormorant Asset Management, LP
13F
Company
0.6%
225,000
$9,990,000 30 Jun 2023
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.54%
202,670
$8,999,000 30 Jun 2023
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.45%
170,578
$7,573,663 30 Jun 2023
13F
FRANKLIN RESOURCES INC
13F
Company
0.42%
157,255
$6,982,122 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.39%
147,055
$6,529,242 30 Jun 2023
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.37%
139,500
$6,193,800 30 Jun 2023
13F
STATE STREET CORP
13F
Company
0.37%
139,403
$6,189,493 30 Jun 2023
13F
Boxer Capital, LLC
13F
Company
0.34%
130,000
$5,772,000 30 Jun 2023
13F
Point72 Asset Management, L.P.
13F
Company
0.33%
125,200
$5,558,880 30 Jun 2023
13F
CHI Advisors LLC
13F
Company
0.33%
125,139
$5,556,172 30 Jun 2023
13F
Invesco Ltd.
13F
Company
0.29%
110,632
$4,912,061 30 Jun 2023
13F
Trustees of Columbia University in the City of New York
13F
Company
0.29%
110,488
$4,905,667 30 Jun 2023
13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
13F
Company
0.24%
90,000
$3,982,500 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.19%
69,975
$3,106,890 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
68,890
$3,059,000 30 Jun 2023
13F
Woodline Partners LP
13F
Company
0.18%
68,146
$3,025,682 30 Jun 2023
13F
ExodusPoint Capital Management, LP
13F
Company
0.14%
52,800
$2,344,000 30 Jun 2023
13F
Parkman Healthcare Partners LLC
13F
Company
0.13%
50,000
$2,220,000 30 Jun 2023
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.13%
48,941
$2,172,980 30 Jun 2023
13F
Informed Momentum Co LLC
13F
Company
0.12%
47,206
$2,095,946 30 Jun 2023
13F
Monashee Investment Management LLC
13F
Company
0.12%
45,000
$1,998,000 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.12%
43,530
$1,932,732 30 Jun 2023
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.11%
43,270
$1,921,188 30 Jun 2023
13F
Blackstone Inc.
13F
Company
0.11%
40,866
$1,814,450 30 Jun 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.11%
40,261
$1,787,588 30 Jun 2023
13F
Ensign Peak Advisors, Inc
13F
Company
0.11%
40,000
$1,776,000 30 Jun 2023
13F
Walleye Capital LLC
13F
Company
0.09%
35,804
$1,589,698 30 Jun 2023
13F

Institutional Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q3 2023

As of 30 Sep 2023, Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,879,838 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Paradigm Biocapital Advisors LP, Novo Holdings A/S, PERCEPTIVE ADVISORS LLC, STATE STREET CORP, VANGUARD GROUP INC, and Frazier Life Sciences Management, L.P.. This page lists 90 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
89
Q3 2023 holders
90
Holder diff
1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .